Arkolith/Insider Trading/SYRE/Form 4

Turtle Cameron

Chief Executive Officer, DirectorSpyre Therapeutics, Inc. (SYRE) · full profile →Form 4 · filed Jan 6, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$460K
Net Open-Market Flow
-$460K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 2, 2026Sell(S)13K$30.47$387K674K
Jan 2, 2026Sell(S)100$32.39$3K672K
Jan 2, 2026Sell(S)2K$31.79$70K672K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001758363-26-000002) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML